Valhi (VHI) Competitors $15.62 -0.13 (-0.79%) As of 01:06 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock VHI vs. CC, PCT, NGVT, BAK, UAN, ECVT, TROX, WLKP, ASIX, and OECShould you be buying Valhi stock or one of its competitors? The main competitors of Valhi include Chemours (CC), PureCycle Technologies (PCT), Ingevity (NGVT), Braskem (BAK), CVR Partners (UAN), Ecovyst (ECVT), Tronox (TROX), Westlake Chemical Partners (WLKP), AdvanSix (ASIX), and Orion (OEC). These companies are all part of the "chemicals" industry. Valhi vs. Chemours PureCycle Technologies Ingevity Braskem CVR Partners Ecovyst Tronox Westlake Chemical Partners AdvanSix Orion Chemours (NYSE:CC) and Valhi (NYSE:VHI) are both small-cap basic materials companies, but which is the superior stock? We will compare the two companies based on the strength of their profitability, risk, media sentiment, valuation, earnings, institutional ownership, analyst recommendations, dividends and community ranking. Is CC or VHI more profitable? Valhi has a net margin of 4.29% compared to Chemours' net margin of 1.51%. Chemours' return on equity of 26.54% beat Valhi's return on equity.Company Net Margins Return on Equity Return on Assets Chemours1.51% 26.54% 2.41% Valhi 4.29%6.90%3.36% Does the MarketBeat Community believe in CC or VHI? Chemours received 404 more outperform votes than Valhi when rated by MarketBeat users. However, 63.34% of users gave Valhi an outperform vote while only 60.51% of users gave Chemours an outperform vote. CompanyUnderperformOutperformChemoursOutperform Votes63960.51% Underperform Votes41739.49% ValhiOutperform Votes23563.34% Underperform Votes13636.66% Do analysts prefer CC or VHI? Chemours currently has a consensus price target of $17.56, indicating a potential upside of 67.12%. Valhi has a consensus price target of $20.00, indicating a potential upside of 28.08%. Given Chemours' stronger consensus rating and higher probable upside, research analysts plainly believe Chemours is more favorable than Valhi.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Chemours 0 Sell rating(s) 4 Hold rating(s) 5 Buy rating(s) 0 Strong Buy rating(s) 2.56Valhi 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Is CC or VHI a better dividend stock? Chemours pays an annual dividend of $0.35 per share and has a dividend yield of 3.3%. Valhi pays an annual dividend of $0.32 per share and has a dividend yield of 2.0%. Chemours pays out 175.0% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Valhi pays out 7.8% of its earnings in the form of a dividend. Which has better valuation & earnings, CC or VHI? Valhi has lower revenue, but higher earnings than Chemours. Valhi is trading at a lower price-to-earnings ratio than Chemours, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioChemours$5.79B0.27-$238M$0.2052.53Valhi$2.11B0.21-$12.10M$4.103.81 Does the media prefer CC or VHI? In the previous week, Chemours had 16 more articles in the media than Valhi. MarketBeat recorded 20 mentions for Chemours and 4 mentions for Valhi. Chemours' average media sentiment score of 0.69 beat Valhi's score of 0.64 indicating that Chemours is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Chemours 7 Very Positive mention(s) 1 Positive mention(s) 3 Neutral mention(s) 3 Negative mention(s) 0 Very Negative mention(s) Positive Valhi 1 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Which has more volatility and risk, CC or VHI? Chemours has a beta of 1.76, meaning that its stock price is 76% more volatile than the S&P 500. Comparatively, Valhi has a beta of 1.33, meaning that its stock price is 33% more volatile than the S&P 500. Do insiders and institutionals believe in CC or VHI? 76.3% of Chemours shares are held by institutional investors. Comparatively, 3.8% of Valhi shares are held by institutional investors. 0.5% of Chemours shares are held by insiders. Comparatively, 0.2% of Valhi shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth. SummaryChemours beats Valhi on 14 of the 20 factors compared between the two stocks. Get Valhi News Delivered to You Automatically Sign up to receive the latest news and ratings for VHI and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart VHI vs. The Competition Export to ExcelMetricValhiIndustrial inorganic chemicals IndustryMaterials SectorNYSE ExchangeMarket Cap$441.83M$25.17B$3.10B$19.26BDividend Yield2.08%3.47%5.20%3.83%P/E Ratio5.0011.4072.4534.34Price / Sales0.212.5125,591,212,775,269,500.0034.56Price / Cash12.6456.3524.3417.51Price / Book0.357.175.234.68Net Income-$12.10M$731.97M$156.48M$1.02B7 Day Performance1.13%-2.85%1.82%-2.66%1 Month Performance-4.07%1.59%4.39%5.98%1 Year Performance-17.56%-28.34%18.51%5.61% Valhi Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)VHIValhi2.6801 of 5 stars$15.62-0.8%$20.00+28.1%-18.6%$441.83M$2.11B5.002,250News CoverageDividend AnnouncementAnalyst UpgradeCCChemours4.6474 of 5 stars$11.19+0.2%$17.56+56.9%-60.1%$1.67B$5.79B19.636,600Trending NewsDividend AnnouncementAnalyst DowngradeAnalyst RevisionGap UpHigh Trading VolumePCTPureCycle Technologies2.1127 of 5 stars$8.78-5.5%$12.00+36.7%+70.4%$1.58B$1.58M-5.85120Positive NewsGap DownNGVTIngevity3.3638 of 5 stars$42.36-1.4%$52.75+24.5%-17.6%$1.54B$1.35B-3.582,050Positive NewsGap UpBAKBraskem2.497 of 5 stars$3.70+2.5%$9.75+163.5%-53.9%$1.47B$78.95B-1.048,310Positive NewsUANCVR Partners2.9292 of 5 stars$83.52+1.9%N/A-1.9%$1.43B$540.53M14.50300Positive NewsHigh Trading VolumeECVTEcovyst4.0338 of 5 stars$7.24-4.4%$10.00+38.1%-21.5%$849.98M$706.15M15.74880Positive NewsGap DownTROXTronox4.7906 of 5 stars$5.30-2.2%$9.64+81.9%-73.2%$837.07M$3.04B-17.106,610Positive NewsGap DownHigh Trading VolumeWLKPWestlake Chemical Partners3.2669 of 5 stars$22.730.0%N/A+0.6%$800.98M$1.09B12.99150Positive NewsASIXAdvanSix3.9053 of 5 stars$24.44+4.1%$33.50+37.1%+0.3%$655.31M$1.56B15.181,460Positive NewsGap UpHigh Trading VolumeOECOrion4.2261 of 5 stars$11.12-2.0%$14.50+30.4%-56.6%$625.72M$1.85B14.831,600Positive NewsGap Down Related Companies and Tools Related Companies Chemours Alternatives PureCycle Technologies Alternatives Ingevity Alternatives Braskem Alternatives CVR Partners Alternatives Ecovyst Alternatives Tronox Alternatives Westlake Chemical Partners Alternatives AdvanSix Alternatives Orion Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:VHI) was last updated on 5/23/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredBuffett’s favorite chart just hit 209% – here’s what that means for goldA Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the ...Golden Portfolio | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredTrump’s Bitcoin Reserve is No Accident…Bitcoin's supply is being drained at unprecedented rates, but while most investors focus solely on Bitcoin, th...Crypto 101 Media | SponsoredIs President Trump Lying To You With This?President Trump’s economic transition isn’t without hardship. But what if there were a smart, tax-free way to ...Colonial Metals | SponsoredJuly 2025 Rule Change to Impact Retirement InvestorsThere's a massive change from a new rule going into effect this July. And it's one the Big Banks are alread...Premier Gold Co | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Valhi, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Valhi With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.